- The Washington Times - Monday, June 10, 2002

LONDON Scientists have determined that a spontaneous change in a certain gene is involved in 70 percent of cases of melanoma, the deadliest form of skin cancer, which kills nearly 40,000 people a year worldwide.
Experts say the finding might lead to more effective drugs for melanoma, which accounts for 11 percent of skin cancer but is hard to treat once it has spread. It also accounts for almost all deaths from skin cancer.
Dr. Paul Meltzer, a senior cancer genetics investigator at the U.S. National Human Genome Research Institute, called the finding the biggest breakthrough in melanoma research in many years.
The discovery, published yesterday in the online version of the journal Nature, is the first fruit of the Cancer Genome Project, a spinoff of the international Human Genome Project being run by researchers at the Wellcome Trust Sanger Institute in Cambridge, England.
Cancer is the disease that lends itself best to an analysis of the human genome because all cancers are a disease of DNA, said Mike Stratton, head of the Cancer Genome Project. The project aims to identify which of the 30,000 human genes are involved in cancer and the role they play.
Genes are made up of a DNA code, represented by a sequence of letters. A mutation occurs when the order of the letters changes.
Mutations can occur in two ways: either when DNA is damaged by such toxins as radiation, chemicals or viruses, or when mistakes are made before cell division.
Each cell in the body contains a copy of the genome and duplicates it before the cell divides into two. The copy isn't always perfect.
Most of the mutations are harmless. However, sometimes a mutation will occur in a particular cell in a key gene, resulting in the gene switching on or off.
That cell then will start to behave abnormally. It will divide when it ought to stop dividing. It will move out of its usual position in a tissue and may even float into the bloodstream and deposit in another organ.
That is how cancer evolves. Experts estimate it takes about 25 years from the first gene mutation for a tumor to appear in an adult.
"With the human DNA sequence now available to us, we have started the lengthy and daunting task of trawling through the vast tracts of genome, gene by gene, to see if we can find the abnormal genes that drive cells to behave as cancers," said Dr. Andy Futreal, a leader of the Cancer Genome Project.
Dr. Meltzer said the melanoma finding raises great hopes that the ambitious Cancer Genome Project will pan out.
The scientists start by looking at the genes in 48 tumor samples containing six common cancers. They take each one of the 30,000 genes of the genome and look for abnormalities.
After that, they look at the suspect genes in a further 1,000 samples of cancerous tissue, derived from nearly every type of human cancer, to see how important a role the gene mutation plays.
The first abnormality they have found is in the gene B-RAF, which is one of a chain of genes, all of which must be switched to the "on" position for a cell to grow and divide.
Normally, it switches on and off, but the scientists found that the mutation makes the gene stay switched on all the time and ignore prompts to turn itself off. The cells with the mutation keep multiplying unchecked, leading to cancer.

Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide